Yes, Vasoactive Intestinal Peptide (VIP) is considered a bronchodilator.
VIP functions as a neurotransmitter and has been shown to relax airway smooth muscle, leading to bronchodilation. This bronchodilatory effect suggests that VIP may have a role in the regulation of airway tone and could potentially be relevant in the context of respiratory conditions like asthma. In fact, research indicates that VIP may be an important natural bronchodilator. This understanding has prompted exploration of its potential therapeutic applications in managing airway constriction in asthma and other respiratory ailments.
